Tru-Scint AD monoclonal antibody kit: Will begin this fall a Phase II/III trial in 150 patients, with enrollment to take one year. A pharmacokinetic and dosing

Biomira Inc. (BIOMF), Edmonton, Alberta Product: Tru-Scint AD monoclonal antibody kit Indication: Detect recurrent breast cancer Status: Will begin this fall a Phase II/III trial in 150 patients, wit...